Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Crizotinib × Lymphoid × Clear all

Phase

Status

Completed 4 Active not recruiting 4 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Lymphoid 1 Dermatologic 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 146 Rituximab 124 venetoclax 72 fludarabine 72 obinutuzumab 58 Specimen Handling 58 Vincristine 53 Doxorubicin 53 Prednisone 52 Lenalidomide 48 Magnetic Resonance Spectroscopy 47 zanubrutinib 44 Biopsy 42 Dexamethasone 41 Cytarabine 38 Methotrexate 33 Bendamustine Hydrochloride 31 fludarabine phosphate 29 acalabrutinib 29 Etoposide 28 blinatumomab 27 glofitamab 24 Immunotherapy, Adoptive 24 ibrutinib 23 Gemcitabine 23 polatuzumab vedotin 22 pirtobrutinib 22 pembrolizumab 19 orelabrutinib 19 Injections 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡